FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease

Common Medications Contain Animal Byproducts – No FDA Regulations to Alert Patients

Study reports six novel variants for CRISPR-Cas12a in plants, expanding genome engineering

UMD reports six novel variants for CRISPR-Cas12a in plants, expanding genome engineering